Comerica Bank’s TG Therapeutics TGTX Stock Holding History

Comerica Bank’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$927K	Sell	31,100 -9,772	-24%	-$319K	﹤0.01%	1560
2025 Q3	$1.48M	Sell	40,872 -5,783	-12%	-$190K	0.01%	1323
2025 Q2	$1.68M	Buy	46,655 +1,352	+3%	+$50.3K	0.01%	1233
2025 Q1	$1.79M	Sell	45,303 -1,425	-3%	-$47.9K	0.01%	1183
2024 Q4	$1.41M	Buy	46,728 +94	+0.2%	+$2.7K	0.01%	1348
2024 Q3	$1.09M	Buy	+46,634	New	+$1.02M	﹤0.01%	1494
2023 Q4	–	Sell	-467	Closed	-$3.9K	–	3828
2023 Q3	$3.9K	Buy	+467	New	+$6.51K	﹤0.01%	3430
2021 Q4	–	Sell	-226,460	Closed	-$7.11M	–	2197
2021 Q3	$7.11M	Buy	226,460 +35,080	+18%	+$1.09M	0.04%	492
2021 Q2	$4.17M	Buy	+191,380	New	+$7.52M	0.02%	825

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Comerica Bank's TGTX Position: Q4 2025 in Review

Comerica Bank reduced its TG Therapeutics (TGTX) stake by 24% in Q4 2025, selling an estimated $319K and leaving 31,100 shares worth $927K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Comerica Bank first reported a position in TGTX in Q2 2021 and has held it in 9 quarters since. The position peaked at $7.11M in Q3 2021. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

Comerica Bank held 31,100 shares of TG Therapeutics worth $927K as of Q4 2025.
Comerica Bank sold 9,772 TG Therapeutics shares in Q4 2025, an estimated $319K.
TG Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1560 holding.
Comerica Bank first reported a position in TG Therapeutics in Q2 2021 and has held it in 9 quarters since.
Comerica Bank's TG Therapeutics position peaked at $7.11M in Q3 2021.
351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.